SHEPHERD CENTER — History
CCN 112003 | 3-year financial timeline | COVID resilience: 37/100
🛡️ Public data only — no PHI permitted on this instance.
$255M
Latest Revenue (FY2022)
+1.3%
Revenue CAGR (3yr)
-20.8%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $248M | $241M | $255M | +5.7% | +1.3% |
| Operating Expenses | $280M | $294M | $308M | +4.9% | +4.9% |
| Operating Margin | -12.7% | -21.7% | -20.8% | +4.1% | +0.0% |
| Net Income | $-31M | $-52M | $-53M | -1.3% | +0.0% |
| Licensed Beds | 132 | 128 | 130 | +1.6% | -0.8% |
| Total Patient Days | 45,579 | 45,562 | 47,153 | +3.5% | +1.7% |
| Medicare Day % | 4% | 4% | 3% | -6.9% | -2.3% |
| Medicaid Day % | 6% | 2% | 1% | -64.9% | -66.7% |
COVID Impact & Recovery
Resilience Score: 37/100 — Distressed — significant COVID damage
Revenue recovery from FY2020 to FY2022: +2.7% ($248M → $255M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+1.3%
This Hospital
+7.6%
State Avg
Latest Margin
-20.8%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $258M | -24.9% |
| FY2024 (proj) | $262M | -28.9% |
| FY2025 (proj) | $265M | -33.0% |